News Focus
News Focus
Followers 22
Posts 4692
Boards Moderated 0
Alias Born 01/27/2022

Re: Number sleven post# 431003

Wednesday, 11/27/2024 1:45:18 PM

Wednesday, November 27, 2024 1:45:18 PM

Post# of 447959
Sleven, I would actually disagree that the company has to be profitable to sell itself. I think the ONLY thing that matters is top line revenue and top line growth. The only costs that really matter in a sale are COGS, because that's the only thing going with the sale of the company.

Nobody is buying "Amarin". They are buying Vascepa. And that product would just get folded into an existing sales line, and the rest of the Amarin overhead goes away. I actually wouldn't mind Amarin running red - even significantly red - if it meant they were doing it to dramatically ramp up revenues.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News